U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
91.31
-0.10 (-0.11%)
Dec 20, 2024, 4:00 PM EST - Market closed
U.S. Physical Therapy Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for USPH stock have an average target of 114, with a low estimate of 108 and a high estimate of 120. The average target predicts an increase of 24.85% from the current stock price of 91.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for USPH stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 0 | 0 | 0 | 0 | 1 |
Buy | 3 | 3 | 2 | 2 | 2 | 3 |
Hold | 0 | 0 | 0 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 3 | 2 | 3 | 3 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $100 → $115 | Hold → Strong Buy | Upgrades | $100 → $115 | +25.94% | Dec 16, 2024 |
JMP Securities | JMP Securities | Buy Initiates $113 | Buy | Initiates | $113 | +23.75% | Dec 16, 2024 |
JP Morgan | JP Morgan | Buy Maintains $117 → $120 | Buy | Maintains | $117 → $120 | +31.42% | Dec 3, 2024 |
Barrington Research | Barrington Research | Buy Maintains $108 | Buy | Maintains | $108 | +18.28% | Nov 21, 2024 |
Barrington Research | Barrington Research | Buy Maintains $108 | Buy | Maintains | $108 | +18.28% | Nov 7, 2024 |
Financial Forecast
Revenue This Year
679.38M
from 598.63M
Increased by 13.49%
Revenue Next Year
763.13M
from 679.38M
Increased by 12.33%
EPS This Year
2.70
from 1.28
Increased by 110.93%
EPS Next Year
2.91
from 2.70
Increased by 7.94%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 705.5M | 815.9M | 876.7M |
Avg | 679.4M | 763.1M | 826.8M |
Low | 647.1M | 716.2M | 770.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 17.9% | 20.1% | 14.9% |
Avg | 13.5% | 12.3% | 8.3% |
Low | 8.1% | 5.4% | 1.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | 3.01 | 3.15 | 3.52 |
Avg | 2.70 | 2.91 | 3.18 |
Low | 2.44 | 2.47 | 2.82 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 135.7% | 16.8% | 20.8% |
Avg | 110.9% | 7.9% | 9.1% |
Low | 90.9% | -8.4% | -3.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.